top of page
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
Poppy seed addiction: A brewing crisis? A novel case series examining patterns, perceptions and potential risks associated with excessive poppy seed use
The increasing incidence of opioid dependence linked to the consumption of unwashed poppy seeds (UPSs) is an emerging public health concern.
Dose-response relationship between blood concentrations of THC and crash culpability risk: An updated meta-regression of culpability studies
A recent meta-analysis in Drug Science, Policy and Law on the risk associated with the detection of tetrahydrocannabinol (THC) in blood and
Matthew A Albrecht Razi Hasan Damir Kekez and Huaqiong Zhou
Mar 271 min read
Irresponsible publicity related to an unpublished vaping study
On the 26th of February 2025, Clive Bates wrote to an academic at Manchester Metropolitan University, Dr Maxime Boidin, about generating irr
Clive Bates
Feb 266 min read
Drug development in psychiatry: 50 years of failure and how to resuscitate it
The past 50 years have seen remarkable advances in the science of medicine. The pharmacological treatments of disorders such as hypertension
David Nutt
Feb 121 min read
Who's asking me? Service user perspectives on safer injecting facilities
This paper discusses the topic of safer injecting facilities with those who are likely to use them. Whilst more countries are adopting this
Petra Salisbury and Darren Hill
Jan 81 min read
The Australia story: Current status and future challenges for the clinical applications of psychedelics
The past decade has seen a huge increase in clinical research with psychedelic drugs and 3,4-methylenedioxymethamphetamine (MDMA)
David J Nutt, Peter Hunt, Anne Katrin Schlag and Paul Fitzgerald
Dec 18, 20241 min read
The Glasgow drug consumption room: A job half done?
This article discusses the introduction of the safe drug consumption facility in Glasgow and considers some of its potential consequences.
Phil Dalgarno and Steve O’Rawe
Oct 28, 20241 min read
Allaying the fears: Midomafetamine with therapy is a medicine
MDMA (now called midomafetamine by the FDA) is a substituted amphetamine first synthesised in 1912 by Merck that has been developed over the
David J Nutt, Tadeusz Hawrot, Peter Hunt and Anne Katrin Schlag
Sep 24, 20243 min read
Drug Science and University College London Collaboration: Advancing MDMA-Assisted Therapy
Drug Science and UCL are pleased to announce their collaboration aimed at advancing our understanding of MDMA-assisted psychotherapy.
James Bunn
Sep 3, 20243 min read
Key Achievements of T21
Since its inception in 2019, T21 has strived to create the largest body of evidence for the safety and efficacy of medical cannabis, providi
Alkyoni Anthanasiou-Fragkouli
Sep 3, 20242 min read
Allaying the fears: MDMA with therapy is a medicine
MDMA has been developed over the past 30 years by the Multidisciplinary Association for Psychedelic Studies as a novel treatment for PTSD.
Prof David Nutt, Tadeusz Hawrot, Peter Hunt, and Dr Anne Katrin Schlag
Aug 6, 202425 min read
Suicidal Ideation in Medicinal Cannabis Patients: A 12-Month Prospective Study
To document the prevalence and correlates of suicidal ideation (SI) among individuals seeking cannabis-based medicinal products (CBMPs); to
James Bunn
Jul 31, 20242 min read
Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well‑Being: Findings from T21
There are important differences between individuals aged 65+ years and younger individuals receiving cannabis-based medicinal products. Olde
Michael Lynskey
Jun 18, 20242 min read
Prescribed Medicinal Cannabis for the Treatment of Chronic Pain Comorbid with Depression: Real World Evidence from Project Twenty21
Chronic pain is one of the most common conditions for which people seek treatment with cannabis-based medicinal products (CBMPs) and there i
Alkyoni Anthanasiou-Fragkouli
Jun 6, 20242 min read
How can we prepare psychiatry for a psychedelic future?
The Therapeutic Goods Administration (TGA) in Australia recently made a groundbreaking decision to reschedule two drugs as treatments for ce
Drug Science
May 23, 20243 min read
In defence of the decriminalisation of drug possession in the UK
Authors Alex Stevens, Niamh Eastwood and Kirstie Douse Published March 24, 2024 Abstract In this review article, we develop the case for...
Alex Stevens, Niamh Eastwood and more
Mar 24, 20241 min read
bottom of page